J. Filippi, R. Altwegg, X. Hebuterne, G. Boschetti, P. Veyrard, et al.. Is golimumab serum level predictive of clinical remission after intensification for loss of response in patients with ulcerative colitis?.
JOURNAL OF CROHNS & COLITIS, 2022, 16 (1), pp.I439.
⟨hal-03665865⟩